rgn-137 LICENSE AgreementLicense Agreement • May 15th, 2014 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2014 Company Industry JurisdictionThis License Agreement (this “Agreement” or this “License Agreement”) is effective as of March 7, 2014 (the “Effective Date”) by and between RegeneRx Biopharmaceuticals, Inc., a company organized and existing under the laws of the state of Delaware, with offices at 15245 Shady Grove Road, Suite 470, Rockville, Maryland, U.S.A. (hereinafter “Licensor”), and Digital Aria Co., Ltd. with offices at 22nd FL, Parkview Tower, 248 Jungjail-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 463-863, Republic of Korea (hereinafter “Licensee”), each a “Party” and, collectively, the “Parties.”
RGN-259 LICENSE AgreementLicense Agreement • May 15th, 2014 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2014 Company Industry JurisdictionThis License Agreement (this “Agreement” or this “License Agreement”) is effective as of March 7, 2014 (the “Effective Date”) by and between RegeneRx Biopharmaceuticals, Inc., a company organized and existing under the laws of the state of Delaware, with offices at 15245 Shady Grove Road, Suite 470, Rockville, Maryland, U.S.A. (hereinafter “Licensor”), and Digital Aria Co., Ltd. with offices at 22nd FL, Parkview Tower, 248 Jungjail-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 463-863, Republic of Korea (hereinafter “Licensee”), each a “Party” and, collectively, the “Parties.”
LICENSE AgreementLicense Agreement • January 16th, 2013 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 16th, 2013 Company Industry Jurisdiction
LICENSE AgreementLicense Agreement • November 14th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 14th, 2012 Company Industry Jurisdiction